Multiple RTOG studies are being covered at the 2024 ASCO Meeting, including a Best of ASCO presentation on RTOG 0848 for chemotherapy +/- chemoradiation for patients with resected head of periampullary pancreas cancer. Check out the program for more: ow.ly/KFww50RJUL0

Did You Know? There are several ways you can participate in RTOG Foundation as a member site, an industry collaborator, or by enrolling in one of our studies. Read more on our website about how you can partner with RTOG Foundation. Learn more at RTOG.org/Partners

Today is Clinical Trials Day! Clinical Trials Day celebrates all that has been accomplished through clinical research as well as shows appreciation for all those behind the scenes, bringing forward these advances in research.

Dr. Danielle Cerbon, one of our RTOG Foundation Communications Interns (2023-2024), delves into where her passion for communications stems from, combining communications and research, and her advice to others. Watch the full interview here: ow.ly/B0hg50RJTmK Danielle Cerbon, MD

The RTOGF website continues to be updated with content that would be helpful for members, partners, and all our audiences to know. For instance, did you know RTOG has an FAQ section under our Resources section? rtog.org/Resources - What would you find helpful on our website?

We interviewed our current RTOGF Communications Intern (2023-2024), Dr. Upadhyay, on his experience with RTOGF, his future goals, and his advice for others. Check out the full video here: ow.ly/NUJS50RFKip Rituraj Upadhyay, MD

ATTN - Please note the NRG 2024 Summer Meeting registration is now open!

As #NationalCancerResearchMonth continues, we highlight the many stats available that focus on the importance of clinical research in cancer. Researching & developing innovative approaches to treatment is what helps us improve outcomes for those impacted by this disease.

Did you know... Participating sites on our studies (such as RTOG 3507 in this example) can be found on certain study webpages of our website? All open and closed studies are available on our website under Clinical Trials: rtog.org/Clinical-Trials

This week marks #NationalNursesWeek ! We are thankful for our nurses not only this week, but every day! This year's theme is 'Nurses Make the Difference'.

Thank you Wally Curran for this important presentation on #lungcancer research in RTOGF and @NRGOnc!

May is #NationalCancerResearchMonth - Research advances have impacted and improved outcomes for people worldwide. May is dedicated to raising awareness of the importance of this research and the need to continue to evolve and change practice for individuals facing this disease.

May kicks off #BrainCancer Awareness Month.

In the last few days of #HeadandNeckCancer Awareness Month - we call your attention to some H&N cancer-related publications from RTOG Foundation trials that you can find linked on the RTOG website here: rtog.org/Clinical-Trial…

Did you know that datasets for MSD-MK 7684A-006 and MSD-MK2870-019 are available when logged into the RTOG website? You can find them here: rtog.org/RTQA

RTOG 3521 is an upcoming study of combo toripalimab + #chemo for recurrent metastatic #nasopharyngeal #cancer - Dr. Spreafico (PI) was interviewed on what our researchers should know about this trial. Read the interview: bit.ly/3THrNWL #HeadAndNeckCancerAwarenessMonth

Check out our New Investigator Spotlight, Dr. Wesley Talcott! Dr. Talcott is at the Zucker School of Med + a #RadOnc at Northwell Health. In our April newsletter, we interviewed Dr. Talcott on his current endeavors, goals, and inspirations. Read the interview: bit.ly/3VGoEt5

The application deadline is less than 2 weeks away for this opportunity for #radonc residents! We are seeking 2 Communications Interns. Deadline for applications is MAY 1ST! Learn more about the position and how to apply: ow.ly/2oGb50R4zSg

Did You Know?: Info regarding the ACR 3518 study, a phase I assessment of hypofractionated postoperative RT (H-PORT) for intermediate-risk H&N cancer, is available on our website? Documents are available after login. Find it here: rtog.org/Clinical-Trial… #HNC

What does Dr. Cerbon have to say about her experience as an RTOGF Communications Intern? Read: ow.ly/kfZR50RgiV0 - Apps are due MAY 1st for future comms interns! $1k stipend + opportunity to get involved with RTOGF #cancerresearch . More info: ow.ly/zGVJ50RgiV4